Antonio R Pera
CIK 1689325 · President, Par Pharmaceutical · last filed 2026-06-10
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.94M
Companies
2
Total Filings
29
Lifetime Open-Market Net
-$1.69M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ANIP | Director | 27,017 | $71.92 | $1.94M | -$1.69M | 12 | 2026-06-10 |
| Endo International plc (ENDP) Delisted | President, Par Pharmaceutical | 65,648 | $0.29 | $19.2K | $0 | 13 | 2019-04-04 |
Recent Filings · Page 2 of 3
29 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-08-14 | ANIP | Notice (144) | −3,000 | -$181.1K | EDGAR |
| 2023-05-24 | ANIP | Grant (A) | +6,865 | $0 | EDGAR |
| 2022-04-29 | ANIP | Grant (A) | +10,049 | $0 | EDGAR |
| 2021-12-09 | ANIP | Buy (P) | +3,000 | $126.8K | EDGAR |
| 2021-03-25 | ANIP | Grant (A) | +9,292 | $0 | EDGAR |
| 2020-08-07 | ANIP | Grant (A) | +7,421 | $0 | EDGAR |
| 2019-04-04 | Endo International plc (ENDP) Delisted | Tax (F) | −11,669 | -$94.5K | EDGAR |
| 2019-04-02 | Endo International plc (ENDP) Delisted | Grant (A) | +46,973 | $0 | EDGAR |
| 2019-02-26 | Endo International plc (ENDP) Delisted | Tax (F) | −186 | -$2.0K | EDGAR |
| 2019-02-25 | Endo International plc (ENDP) Delisted | Tax (F) | −2,528 | -$26.2K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.